Account Review

Pfizer, J&J creative reviews 'meh' on the medical side

Pfizer, J&J creative reviews 'meh' on the medical side

By

For the big mainline ad agencies, the recent creative consolidations at Pfizer and Johnson & Johnson are a big deal, but to their medical agency subsidiaries, they mostly represent a codification of where things stood to begin with.

Indie shops rally to retain business as Merck consolidates advertising

By

Merck, one of the biggest spenders in pharma advertising, said it is consolidating its US creative business.

Pfizer shifts global Lipitor PR to Ketchum

Pfizer awarded Ketchum a global assignment for Lipitor as the pharmaceutical company prepares for its top-selling drug to go off patent at the end of this year.

GSK taps Omnicom's PHD as media agency of record

By

GlaxoSmithKline tapped Omnicom's PHD as media agency of record on all of its healthcare products, ousting incumbent WPP's MediaCom.

GSK shortlists 20 in US Rx advertising review

By

A sprawling review of GlaxoSmithKline's advertising business on US pharmaceutical brands is down to a shortlist of 20 agency networks.

Sanofi-Aventis to reassign global media duties

By

Sanofi-Aventis put its global media buying and planning account up for review, a spokesperson for the company confirmed today.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.